Analyst consensus rating
Pliant Therapeutics Analyst Rating: Hold
PLRX is rated Hold by 2 analysts with a $2.50 target. As of 2026-08-20.
Direct answer
Pliant Therapeutics's consensus rating is Hold.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $2.50.
Forecast evidence checked August 20, 2026.
Get free Pliant Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.12
- Average price target
- $2.50
- High price target
- $3.00
- Low price target
- $2.00
- Low target gap
- +78.6%
- Target upside
- +123.2%
- High target gap
- +167.9%
- Target range width
- 89.3%
- Consensus rating
- Hold
- Analysts
- 2
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pliant Therapeutics?
Pliant Therapeutics has a verified Hold consensus. The same dataset has an average price target of $2.50.
How far are Pliant Therapeutics's low and high targets from the recorded price?
The low target implies +78.6%, while the high target implies +167.9%.
How many analysts are included in Pliant Therapeutics's consensus?
The verified consensus includes 2 analysts.
How is Pliant Therapeutics's target upside or downside calculated?
The average target of $2.50 is divided by the recorded price of $1.12, then one is subtracted to produce +123.2%. This does not guarantee a future return.
When was Pliant Therapeutics's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.